EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GPCR Inhibitors Have Antiviral Properties against JC Polyomavirus Infection

Amanda L Sandberg, Avery C S Bond, Lucas J Bennett, Sophie E Craig, David P Winski, Lara C Kirkby, Abby R Kraemer, Kristina G Kelly, Samuel T Hess, Melissa S Maginnis

Viruses · 2024

DOI: 10.3390/v16101559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Amanda L Sandberg und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA. Hauptthemen laut MEDLINE: JC Virus, Antiviral Agents, Receptors, G-Protein-Coupled, Virus Internalization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

JC polyomavirus (JCPyV) infects the majority of the population and initially establishes a persistent but asymptomatic infection of the kidneys. In healthy individuals, the infection remains controlled by the host immune system, but for individuals experiencing prolonged immunosuppression, the infection can reactivate and spread to the brain, where it causes progressive multifocal leukoencephalopathy (PML), which is a fatal neurodegenerative disease. Currently, there are no approved therapies to treat PML, and affected individuals suffer rapid motor weakness and cognitive deterioration. To identify novel therapeutic treatments for JCPyV infection, receptor agonists/antagonists identified in a previously published drug screen were evaluated for their antiviral properties. Seven drugs were selected and validated using infectivity assays, and the mechanism of inhibition was further explored for G protein coupled receptor (GPCR)-associated inhibitors due to the role of the GPCR 5-hydroxytryptamine 2 receptors (5-HT2Rs) in JCPyV entry. The inhibitors cetirizine and paroxetine both reduced infection early in the JCPyV infectious cycle. Paroxetine specifically reduced viral internalization through altering the receptor density of 5-HT2CR, inhibiting β-arrestin recruitment to the receptor, and reducing MAPK signaling through ERK. These findings highlight the potential of receptor signaling and viral entry mechanisms as possible targets for antiviral drug development. Further, this research suggests that FDA-approved receptor agonists/antagonists currently used to treat other medical conditions could be repurposed into antivirals for the possible treatment of JCPyV infection and the fatal disease PML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

JC VirusAntiviral AgentsReceptors, G-Protein-CoupledVirus InternalizationHumansLeukoencephalopathy, Progressive MultifocalPolyomavirus Infections

Stichwörter der Autor:innen

5-HT2RsGPCR agonists/antagonistsJC polyomavirusPMLcetirizineparoxetineprogressive multifocal leukoencephalopathysuper-resolution microscopyβ-arrestin

Substanzen

Antiviral AgentsReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA.
  • Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME 04469, USA.
  • Department of Physics & Astronomy, University of Maine, Orono, ME 04469, USA.

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of General Medical Sciences
  • Centers of Biomedical Research Excellence (COBRE) through the National Institute of General Medical Sciences
  • National Institutes of Health
  • UMaine Institute of Medicine, the UMaine Vice President for Research, Maine Technology Institute
  • COBRE Microscopy and Image Analysis Core (MIAC)

Zitieren

APA

Sandberg, A. L., Bond, A. C. S., Bennett, L. J., Craig, S. E., Winski, D. P., Kirkby, L. C., Kraemer, A. R., Kelly, K. G., Hess, S. T., & Maginnis, M. S. (2024). GPCR Inhibitors Have Antiviral Properties against JC Polyomavirus Infection. Viruses. https://doi.org/10.3390/v16101559

Vancouver

Sandberg AL, Bond ACS, Bennett LJ, Craig SE, Winski DP, Kirkby LC, et al. GPCR Inhibitors Have Antiviral Properties against JC Polyomavirus Infection. Viruses. 2024. doi:10.3390/v16101559

BibTeX
@article{Sandberg2024,
  author = {Sandberg, Amanda L and Bond, Avery C S and Bennett, Lucas J and Craig, Sophie E and Winski, David P and Kirkby, Lara C and Kraemer, Abby R and Kelly, Kristina G and Hess, Samuel T and Maginnis, Melissa S},
  title = {GPCR Inhibitors Have Antiviral Properties against JC Polyomavirus Infection},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16101559}
}
Kostenlos starten →